Advanced search
1 file | 717.97 KB

A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients

(2017) CLINICAL CANCER RESEARCH. 23(8). p.2006-2018
Author
Organization
Keywords
CPG ISLAND HYPERMETHYLATION, HIPPEL-LINDAU GENE, CARCINOMA, MUTATIONS, EXPRESSION, PROGNOSIS, INACTIVATION, NETHERLANDS, EVOLUTION, RECEPTOR

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 717.97 KB

Citation

Please use this url to cite or link to this publication:

Chicago
van Vlodrop, Iris JH, Sophie C Joosten, Tim De Meyer, Kim M Smits, Leander Van Neste, Veerle Melotte, Marcella MLL Baldewijns, et al. 2017. “A Four-gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.” Clinical Cancer Research 23 (8): 2006–2018.
APA
van Vlodrop, I. J., Joosten, S. C., De Meyer, T., Smits, K. M., Van Neste, L., Melotte, V., Baldewijns, M. M., et al. (2017). A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients. CLINICAL CANCER RESEARCH, 23(8), 2006–2018.
Vancouver
1.
van Vlodrop IJ, Joosten SC, De Meyer T, Smits KM, Van Neste L, Melotte V, et al. A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients. CLINICAL CANCER RESEARCH. 2017;23(8):2006–18.
MLA
van Vlodrop, Iris JH, Sophie C Joosten, Tim De Meyer, et al. “A Four-gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients.” CLINICAL CANCER RESEARCH 23.8 (2017): 2006–2018. Print.
@article{8509339,
  author       = {van Vlodrop, Iris JH and Joosten, Sophie C and De Meyer, Tim and Smits, Kim M and Van Neste, Leander and Melotte, Veerle and Baldewijns, Marcella MLL and Schouten, Leo J and van den Brandt, Piet A and Jeschke, Jana and Yi, Joo Mi and Schuebel, Kornel E and Ahuja, Nita and Herman, James G and Aarts, Maureen J and Bosman, Fred T and Van Criekinge, Wim and van Engeland, Manon},
  issn         = {1078-0432},
  journal      = {CLINICAL CANCER RESEARCH},
  keyword      = {CPG ISLAND HYPERMETHYLATION,HIPPEL-LINDAU GENE,CARCINOMA,MUTATIONS,EXPRESSION,PROGNOSIS,INACTIVATION,NETHERLANDS,EVOLUTION,RECEPTOR},
  language     = {eng},
  number       = {8},
  pages        = {2006--2018},
  title        = {A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients},
  url          = {http://dx.doi.org/10.1158/1078-0432.ccr-16-1236},
  volume       = {23},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: